HomeAI · summaries
Storia in 2 fonti
Chinese drugmaker CSPC and AstraZeneca to jointly build next-gen biologics manufacturing plant
Chinese drugmaker CSPC Pharmaceutical Group said on Wednesday that it had signed a contract with AstraZeneca to establish a joint venture to build a next-generation biologics manufacturing plant in Shijiazhuang, Hebei province.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
global.chinadaily.com.cn
Chinese drugmaker CSPC and AstraZeneca to jointly build next-gen biologics manufacturing plant
Chinese drugmaker CSPC Pharmaceutical Group said on Wednesday that it had signed a contract with AstraZeneca to establish a joint venture to build a next-generation biologics…
- ·
fiercepharma.com
AstraZeneca, CSPC to form joint venture for biologics manufacturing
AstraZeneca and CSPC Pharmaceutical are strengthening their partnership by establishing a new biologics manufacturing joint venture in China. | AstraZeneca and CSPC…